Novartis AG ADR stock grades by Barron's. View NVS fundamental and sentiment analysis powered by MarketGrader.

FRANKFURT, March 20 (Reuters) - Swiss drugmaker Novartis on Friday agreed to buy a breast cancer drug candidate for up to $3 billion from U.S. biotech firm Synnovation Therapeutics, adding a targeted ...

Novartis inks agreement with Synnovation Therapeutics to acquire a pan-mutant-selective PI3Ka inhibitor: Basel Saturday, March 21, 2026, 10:00 Hrs [IST] Novartis announced that it ...

Plans to build 204 homes on the former Novartis site have been approved by Horsham District Council ...